Vertebral MRI-based radiomics model to differentiate multiple myeloma from metastases: influence of features number on logistic regression model performance

被引:19
|
作者
Liu, Jianfang [1 ]
Guo, Wei [1 ]
Zeng, Piaoe [1 ]
Geng, Yayuan [2 ]
Liu, Yan [3 ]
Ouyang, Hanqiang [4 ]
Lang, Ning [1 ]
Yuan, Huishu [1 ]
机构
[1] Peking Univ Third Hosp, Dept Radiol, 49 North Garden Rd, Beijing 100191, Peoples R China
[2] Huiying Med Technol Co Ltd, Dongsheng Sci & Technol Pk, Beijing 100192, Peoples R China
[3] Peking Univ Third Hosp, Lymphoma Res Ctr, Dept Hematol, 49 North Garden Rd, Beijing 100191, Peoples R China
[4] Peking Univ Third Hosp, Dept Orthoped, 49 North Garden Rd, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
Metastases; Multiple myeloma; Radiomics; Magnetic resonance imaging; CANCER; PRECISION; MEDICINE; EVENTS;
D O I
10.1007/s00330-021-08150-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives This study aimed to use the most frequent features to establish a vertebral MRI-based radiomics model that could differentiate multiple myeloma (MM) from metastases and compare the model performance with different features number. Methods We retrospectively analyzed conventional MRI (T1WI and fat-suppression T2WI) of 103 MM patients and 138 patients with metastases. The feature selection process included four steps. The first three steps defined as conventional feature selection (CFS), carried out 50 times (ten times with 5-fold cross-validation), included variance threshold, SelectKBest, and least absolute shrinkage and selection operator. The most frequent fixed features were selected for modeling during the last step. The number of events per independent variable (EPV) is the number of patients in a smaller subgroup divided by the number of radiomics features considered in developing the prediction model. The EPV values considered were 5, 10, 15, and 20. Therefore, we constructed four models using the top 16, 8, 6, and 4 most frequent features, respectively. The models constructed with features selected by CFS were also compared. Results The AUCs of 20EPV-Model, 15EPV-Model, and CSF-Model (AUC = 0.71, 0.81, and 0.78) were poor than 10EPV-Model (AUC = 0.84, p < 0.001). The AUC of 10EPV-Model was comparable with 5EPV-Model (AUC = 0.85, p = 0.480). Conclusions The radiomics model constructed with an appropriate small number of the most frequent features could well distinguish metastases from MM based on conventional vertebral MRI. Based on our results, we recommend following the 10 EPV as the rule of thumb for feature selection.
引用
收藏
页码:572 / 581
页数:10
相关论文
共 34 条
  • [31] Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder
    Luo, Xiao
    Li, Haiqing
    Xia, Wei
    Quan, Chao
    Zhangbao, Jingzi
    Tan, Hongmei
    Wang, Na
    Bao, Yifang
    Geng, Daoying
    Li, Yuxin
    Yang, Liqin
    EUROPEAN RADIOLOGY, 2024, 34 (07) : 4364 - 4375
  • [32] Classification of Endometrial Lesions by Nuclear Morphometry Features Extracted from Liquid-based Cytology Samples A System Based on Logistic Regression Model
    Zygouris, Dimitrios
    Pouliakis, Abraham
    Margari, Niki
    Chrelias, Charalampos
    Terzakis, Emmanouil
    Koureas, Nikolaos
    Panayiotides, Ioannis
    Karakitsos, Petros
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2014, 36 (04): : 189 - 198
  • [33] Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis
    Liu, Jingjing
    Hu, Lei
    Zhou, Bi
    Wu, Chungen
    Cheng, Yingsheng
    TRANSLATIONAL ONCOLOGY, 2022, 18
  • [34] Machine Learning Model Based on Optimized Radiomics Feature from 18F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A Preliminary Study
    Ni, Beiwen
    Huang, Gan
    Huang, Honghui
    Wang, Ting
    Han, Xiaofeng
    Shen, Lijing
    Chen, Yumei
    Hou, Jian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)